Global Clinical trials Market is growing at a CAGR of 5.7% by 2025
Clinical
trials, research studies
performed on humans, are designed to gain specific information about biomedical
interventions such as vaccines, treatments and drugs in order to prove the
safety and efficacy of the products.
The Clinical
Trial Market accounted for USD
43.7 Billion in 2018 and is projected to reach USD 62.5 Billion by 2025, at a CAGR of 5.7% over the forecast
period.
The driving factor of Clinical Trial Market is globalization of clinical trials,
development of new treatments such as personalized medicine, augmenting
evolution in technology, and boosting demand for CROs to conduct clinical
trials.
Globalization of clinical trial has led to increase in
investment in new product development in emerging countries thereby, having a
positive impact on overall market. The availability of the vast array of
services from drug discovery to post-marketing surveillance has further
simplified the life for mid-size and small-scale pharmaceutical and
biotechnological organizations by providing them the option to outsource what
they think is beyond their core expertise. For instance, Pfizer currently has
three CROs working with it to enhance its product portfolio and drive
innovation. According to the partnership agreement with ICON in 2011, Pfizer
would only preserve the scientific ownership for the trials and studies
conducted by ICON, hence allowing the company to focus and further develop its
capabilities in clinical trial designing.
By region, North America has dominated the
Clinical Trial Market and has generated USD XX million market value in 2017 and
is estimated to reach USD XX million market by 2025 with growing XX% CAGR. The
region has dominated the market as it has presence of big outsourcing firms and
increasing R&D in the region.
Request Sample Visit : https://www.ozonemarketreports.com/sample-request/global-clinical-trial-market-research-report/26981
The major participants in the global Clinical Trial
Market include Quintiles IMS, Paraxel International Corporation, Charles River
Laboratories, ICON plc, SGS SA, Chiltern, Omnicare, PPD, Kendle and
others.
Market Segmentation:
Clinical Trial Market is segmented based on Phase,
Design, Indication and geography.
Market segmented by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market segmented by Design
- Treatment Studies
- Randomized Control Trial
- Adaptive Clinical TrialNon-Randomized Control Trial
- Observational Studies
- Cohort Study
- Case Control Study
- Cross Sectional Study
- Ecological Study
- Expanded Access
Market segmented by Indication
- Autoimmune/inflammation
- Pain management
- Oncology
- CNS condition
- Diabetes
- Obesity
- Cardiovascular
Market segmented by region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Key Players
- Quintiles IMS
- Paraxel International Corporation
- Charles River Laboratories
- ICON plc
- SGS SA
- Chiltern
- Omnicare
- PPD
- Kendle
Target Audience
- Vendors
- Raw material manufacturers
- Research organizations
- Investors and venture capitalists
- Sales Distribution Channel
- Technology manufacturers
- End-users
Browse
Similar Report @ https://www.ozonemarketreports.com/category/pharmaceuticals-and-healthcare/11
ABOUT US
Ozone Market Reports is committed towards
delivering intensive research based analysis reports, enabling clients to easily
make fact-based decisions. We also have with us the facility of our
innovatively designed and developed data processing and analysis division.
Ozone Market Reports is a research-based
consulting firm specializing in getting research inputs and using them
appropriately in the marketing planning process. In saying this, we are trying
to convey that we always attempt to interpret the research data from the
viewpoint of recommending action priorities - both short-term and long-term. To
this end, we have put together a team that understands not only research
techniques, but also branding concepts in depth. We believe our people are
our clients' biggest assets hence we do our best to recruit multi-skilled
individuals, and then give them an environment where they can think and ideate
freely.
We offer various services for our clients to
help them choose what's most relevant and best for them required for their
business.
Contact Us:
Name:
Steven Samuel
Email
- info@ozonemarketreports.com
Phone
- +91 9370882135
Comments
Post a Comment